If you could vote on Brexit now which option would you choose?

Altamira Therapeutics Receives Approval to Commence Clinical Trial Evaluating Bentrio in the Treatment of COVID-19

Altamira Therapeutics Ltd. a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its affiliate, Altamira Medica, has received the necessary approvals to initiate a clinical investigation of Bentrio™ in COVID-19 patients (the “COVAMID” study). COVAMID is a randomized, placebo controlled clinical trial to evaluate the ability of Bentrio™ nasal spray to reduce the SARS-CoV-2 viral load in the nose, alleviate COVID-19 signs and symptoms, and decrease the frequency of COVID-19 related hospital admissions.

The Associated Press - March 9, 2022

View the full story here: https://apnews.com/press-release/accesswire/covid-business-health-bermuda-clinical-trials-2f249f6c906dc4a5d77c0b166791fd7d